Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chemotherapy
Low-dose GM-CSF used as salvage therapy in breast and genital tract carcinoma
November 17th, 2005
Continuous low-dose GM-CSF could be used as salvage therapy in refractory recurrent breast and female genital tract carcinoma. According to recent research from Germany, "GM-CSF (sargramostim [Leukine]) is a powerful cytokine that is able to stimulate the generation of dendritic cells. Adjuvant treatment with continuous low-dose GM-CSF has been shown to prolong survival of stage III/IV melanoma patients." "Data on continuous low-dose GM-CSF therapy in tumors other than prostate cancer are still lacking. This pilot trial was initiated in order to evaluate the efficacy and tolerability of continuous low-dose GM-CSF as salvage in various...
Source: Women's Health Weekly (2005-11-17)
|
